Putting the Foxes in Charge of the Henhouse: The Dramatic Race to Develop an Artificial Pancreas
The true story of how artificial pancreas systems moved from an idea to a therapy, improving the lives of millions…
Breakthrough T1D shares the latest research at ISPAD
At the 2024 International Society for Pediatric and Adolescent Diabetes (ISPAD) Conference in Lisbon, Portugal, the world’s leading diabetes researchers,…
ADA Takeaways: Day 2
At the ADA Scientific Sessions, scientists will present the latest T1D research, all with the goal of improving lives for…
Powering research breakthroughs
We invest in the most promising research to turn ideas into life-changing therapies and lead the way to cures.
The Smallest Artificial Pancreas System Receives FDA Clearance
Tandem Mobi—a miniature-sized insulin pump, for use with Tandem’s Control-IQ™ technology and a compatible CGM—received FDA clearance.
Top Type 1 Diabetes Advances of Fiscal Year 2023
Breakthrough T1D highlights the top type 1 diabetes advances we've seen during fiscal year 2023, including cures and life-improving therapies.
FDA Clears a New Artificial Pancreas System
The FDA cleared the iLet Insulin-Only Bionic Pancreas System for people 6 years of age and older with type 1…
FDA Approves Medtronic 780G Artificial Pancreas System
FDA approved the Medtronic 780G artificial pancreas system, providing automatic adjustments and corrections to blood-sugar levels.
A Bittersweet Goodbye for Breakthrough T1D Champion Cynthia Rice
JDRF’s Chief Mission Strategy Officer will leave behind quite a legacy once she steps down from her role at Breakthrough…
FDA Authorizes Tidepool Loop, an Automated Insulin Dosing App
The FDA authorized the Tidepool Loop, an algorithm that could be used to work with commercially available insulin pumps and…
